The impact of intraoperative autologous blood transfusion during type III radical hysterectomy for early-stage cervical cancer

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 6, 1999, Pages 1310-1316

  Mirhashemi, Ramin ^a   Averette, Hervy E ^b   Deepika, Krishnaprasad ^b   Estape, Ricardo ^b   Angioli, Roberto ^b   Martin, Jorge ^b   Rodriguez, Michael ^b   Penalver, Manuel A ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Cell Saver; Cervical cancer; Intraoperative autologous blood transfusion; Radical hysterectomy

Indexed keywords

ADULT; BLOOD AUTOTRANSFUSION; CANCER MORTALITY; CANCER RECURRENCE; CONFERENCE PAPER; CONTROLLED STUDY; EARLY CANCER; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPHADENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADICAL HYSTERECTOMY; SAFETY; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0033398071     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70369-8     Document Type: Conference Paper

References (28)

1. 1. Williamson KR, Taswell HF. Intraoperative blood salvage: a review. Transfusion 1991;31:662-75.
2. 2. Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F. Prospective surgical-pathologic study of disease free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 1990;38:352-7.
3. 3. Averette HE, Nguyen HN, Donato DM, Penalver MA, Sevin BU, Estape R, et al. Radical hysterectomy for invasive cervical cancer: a 25 year prospective experience with the Miami technique. Cancer 1993;71:1422-37.
4. 3a. Meigs JV. Radical hysterectomy with bilateral dissection of pelvic lymph nodes: surgical treatment of cancer of the cervix. New York: Grune & Stratton; 1954.
5. 4. Zander J, Baltzer J, Lohe KJ, Ober KG, Kaufmann C. Carcinoma of the cervix: an attempt to individualize treatment. Result of a 20 year cooperative study. Am J Obstet Gynecol 1981;139:752-9.
6. 5. Benjamin I, Barakat RR, Curtin JP, Jones WB, Lewis JL, Hoskins WJ. Blood transfusion for radical hysterectomy before and after the discovery of transfusion related human immunodeficiency virus infection. Obstet Gynecol 1994;84:974-8.
7. 6. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg 1986;152:479-82.
8. 7. Brunson ME, Alexander JW. Mechanisms of transfusion induced immunosuppression. Transfusion 1990;30:651-8.
9. 8. Mezrow CK, Bergstein I, Tartter PI. Postoperative infection following autologous and homologous blood transfusion. Transfusion 1992;32:27-30.
10. 9. Weiden PL, Bean MA, Schultz P. Perioperative blood transfusion does not increase the risk of colorectal cancer recurrence. Cancer 1987;1987:870-4.
11. 10. McClinton S, Moffat LE, Scott S, Urbaniak SJ, Kerridge DF. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990;77:140-2.
12. 11. Heal JM, Chang C, Blumberg N. Perioperative blood transfusion and prostate cancer recurrence and survival. Am J Surg 1988;156:374-80.
13. 12. Blumberg N, Heal JM. Transfusion and host defenses against cancer recurrence and infection. Transfusion 1989;29:236-45.
14. 13. Eisenkop SM, Spirtos NM, Montag TW, Moossazadeh J, Warren F, Hendrickson M. The clinical significance of blood transfusion at the time of radical hysterectomy. Obstet Gynecol 1990;76: 110-3.
15. 14. Soper JT, Berchuck A, Clarke-Pearson DL. The clinical significance of blood transfusion at the time of radical hysterectomy [letter]. Obstet Gynecol 1991;77:165-6.
16. 15. Monk BJ, Krisnansu T, Gamboa-Vujicic G, Burger RA, Manetta A, Berman ML. Does perioperative blood transfusion affect survival in patients with cervical cancer treated with radical hysterectomy? Obstet Gynecol 1995;85:343-8.
17. 16. Anonymous. Autologous blood transfusions. Council on Scientific Affairs. JAMA 1986;256:2378-80.
18. 17. Hart OJ, Klimberg IW, Wajsman Z, Baker J. Intraoperative autotransfusion in radical cystectomy for carcinoma of the bladder. Surg Gynecol Obstet 1989;168:302-6.
19. 18. Sevin B, Rarnos R, Gerhardt RI, Guerra L, Hilsenbeck S, Averette HE. Comparative efficacy of short-term versus long-term cefoxitin prophylaxis against postoperative infection after radical hysterectomy: a prospective study. Obstet Gynecol 1991;77:729-34.
20. 19. American College of Obstetricians and Gynecologists. Blood component therapy. Washington: The College; 1994. ACOG Technical Bulletin No.: 199.
21. 20. Dodd RY. Will blood products be free of infectious agents? In: Nance SJ, editor. Transfusion medicine in the 1990's. Arlington (VA): American Association of Blood Banks; 1990. p. 223-51.
22. 21. Cumming PD, Wallace EL, Schorr JB, Dodd RY. Exposure of patients to human immunodeficiency virus through the transfusion of blood components that test antibody negative. N Engl J Med 1989;321:941-6.
23. 22. Sazama K. Reports of 355 transfusion associated deaths: 1976 through 1985. Transfusion 1990;30:583-90.
24. 23. Price FV, Kelley JL, Edwards RP, Hasley PB, Amin RM. A survey of blood transfusion practices of gynecologic oncologists. Gynecol Oncol 1995;59:45-50.
25. 24. Devine P, Linden JV, Hoffstadter LK, Postoway N, Hines D. Blood donor-, apheresis-, and transfusion-related activities: results of the 1991 American Association of Blood Blanks institutional membership questionnaire. Transfusion 1993;33:779-82.
26. 25. Vamvakas EC. Perioperative blood transfusion and cancer recurrence: meta-analysis for explanation. Transfusion 1995;35:760-8.
27. 26. Morris PC, Haugen J, Tomjack J, Anderson B, Buller RE. Blood transfusion and the risk of recurrence in stage IB cervical cancer. Gynecol Oncol 1995;57:401-6.
28. 27. Connor JP, Morris PC, Alagoz T, Anderson B, Bottles K, Buller RE. Intraoperative autologons blood collection and autotransfusion in the surgical management of early cancers of the uterine cervix. Obstet Gynecol 1995;86:373-7.